NCT02245503View on ClinicalTrials.gov

Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

CompletedOBSERVATIONAL
Enrollment

7,391

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2003

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245503 - Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) | Biotech Hunter | Biotech Hunter